Inventor · disambiguated record
Andrew Thompson
Also filed as: THOMPSON ANDREW · THOMPSON ANDREW M · THOMPSON ANDREW MARK
22 granted patents·5 pending applications·2,087 citations·filing 1988–2024
97Inventor score
Files withWARNER LAMBERT CO9BIOGEN MA INC3IO THERAPEUTICS INC3BIOGEN IDEC INC2SUNESIS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
27 records- 0198US6455534B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·274 cites·18 claims
- 0298US5654307ABicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Aug 5, 1997·479 cites·2 claims
- 0397US6265410B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Jul 24, 2001·306 cites·45 claims
- 0497US6084095ASubstituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 4, 2000·292 cites·2 claims
- 0597US5679683ATricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Oct 21, 1997·306 cites·2 claims
- 0696US10590059B2Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoidsIO THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·17 cites·17 claims
- 0796US6596726B1Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 22, 2003·232 cites·10 claims
- 0891US9944622B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·8 cites·16 claims
- 0991US9353087B2Inhibitors of Bruton's tyrosine kinaseBIOGEN IDEC INC·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 1089US9394277B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2013·Granted Jul 19, 2016·11 cites·26 claims
- 1186US5464861A2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor propertiesWARNER LAMBERT CO·Filed 1993·Granted Nov 7, 1995·64 cites·14 claims
- 1285US5556874A2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor propertiesWARNER LAMBERT CO·Filed 1995·Granted Sep 17, 1996·36 cites·34 claims
- 1384US10919835B2Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoidsIO THERAPEUTICS INC·Filed 2020·Granted Feb 16, 2021·1 cites·17 claims
- 1484US10618887B2Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·3 cites·17 claims
- 1583US2024417389A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1678US9174943B2Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compoundsJAIN RAJENDRA PARASMAL·Filed 2013·Granted Nov 3, 2015·4 cites·20 claims
- 1778US7094798B1Inhibitors of checkpoint kinases (Wee1 and Chk1)PFIZER·Filed 2003·Granted Aug 22, 2006·10 cites·9 claims
- 1877US2023174511A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1971US7666864B2Bicyclic nitroimidazole-substituted phenyl oxazolidinonesGLOBAL ALLIANCE FOR TB DRUG DE·Filed 2009·Granted Feb 23, 2010·3 cites·15 claims
- 2071US2021139404A1Compounds and synthetic methods for the preparation of retinoid x receptor-specific retinoidsIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2169US6150359ANaphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferationWARNER LAMBERT CO·Filed 1998·Granted Nov 21, 2000·26 cites·65 claims
- 2268US2021017155A1Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2365US8293734B2Nitroimidazooxazine and nitroimidazooxazole analogues and their usesTHOMPSON ANDREW MARK·Filed 2010·Granted Oct 23, 2012·2 cites·6 claims
- 2463US10189817B2Inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·0 cites·6 claims
- 2554US2017114039A1Inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2646US4868204AMycalamide compounds, compositions thereof and methods of preparation and useHARBOR BRANCH OCEANOGRAPHIC·Filed 1988·Granted Sep 19, 1989·5 cites·22 claims
- 2733US9198913B2Nitroimidazooxazines and their uses in anti-tubercular therapyDENNY WILLIAM ALEXANDER·Filed 2010·Granted Dec 1, 2015·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →